YPrime Named a Leader in Everest Group's 2025 eCOA PEAK Matrix® Assessment
1. YPrime recognized as a Leader in eCOA by Everest Group 2025. 2. The platform supports complex clinical trials with advanced technology. 3. YPrime's innovations improve efficiency in clinical trial processes. 4. AI-powered tools facilitate faster multilingual study launches. 5. YPrime's glucometer integration addresses needs for metabolic trials.